Literature DB >> 12598083

Connexin43 as a determinant of myocardial infarct size following coronary occlusion in mice.

Shigeto Kanno1, Attila Kovacs, Kathryn A Yamada, Jeffrey E Saffitz.   

Abstract

OBJECTIVES: The purpose of this study was to define the role of cell-cell coupling as an independent determinant of infarct size following coronary occlusion.
BACKGROUND: Electrical uncoupling induced by acute ischemia enhances arrhythmogenesis, but it may also protect the heart by limiting intercellular spread of chemical mediators of injury.
METHODS: The left anterior descending coronary artery was ligated in wild-type (Cx43(+/+)) mice and Cx43-deficient (Cx43(+/-)) mice that are heterozygous for a null allele in the gene encoding the major gap junction channel protein, connexin43 (Cx43). Ventricular remodeling and infarct size were compared in both groups.
RESULTS: Echocardiography at 1 and 10 weeks after infarction showed that left ventricular end-diastolic volume and mass increased and ejection fraction decreased in proportion to infarct size in both Cx43(+/-) and Cx43(+/+) hearts. However, infarct size measured histologically in healing infarcts (eight days after infarction) was 29% smaller in Cx43(+/-) hearts (17 +/- 14% of total left ventricular area, n = 30) than in Cx43(+/+) hearts (24 +/- 15%, n = 23; p = 0.037). Fully healed infarcts were smaller than healing infarcts, owing to resorption of necrotic tissue and maturation of scar, but infarct size at 10 weeks after coronary occlusion was still smaller (by 50%) in Cx43(+/-) hearts (6 +/- 5%, n = 9) compared with Cx43(+/+) hearts (12 +/- 7%, n = 17; p = 0.037).
CONCLUSIONS: Cx43-deficient mice develop smaller infarcts than wild-type mice following coronary ligation. New therapies designed to decrease the risk of arrhythmias by enhancing intercellular communication could lead to larger infarcts caused by persistent coronary occlusion.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12598083     DOI: 10.1016/s0735-1097(02)02893-0

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  35 in total

1.  Enhanced effect of gap junction uncouplers on macroscopic electrical properties of reperfused myocardium.

Authors:  Antonio Rodriguez-Sinovas; David García-Dorado; Marisol Ruiz-Meana; Jordi Soler-Soler
Journal:  J Physiol       Date:  2004-06-24       Impact factor: 5.182

Review 2.  Regenerative therapies in electrophysiology and pacing: introducing the next steps.

Authors:  Gerard J J Boink; Michael R Rosen
Journal:  J Interv Card Electrophysiol       Date:  2010-12-16       Impact factor: 1.900

3.  Low connexin channel-dependent intercellular communication in human adult hematopoietic progenitor/stem cells: probing mechanisms of autologous stem cell therapy.

Authors:  Jian Yang; Richard L Darley; Maurice Hallett; W Howard Evans
Journal:  Cell Commun Adhes       Date:  2009-12

Review 4.  Remodeling of gap junctions in ischemic and nonischemic forms of heart disease.

Authors:  Jeffrey E Saffitz; Kiyomi Yamada Hames; Shigeto Kanno
Journal:  J Membr Biol       Date:  2007-06-22       Impact factor: 1.843

Review 5.  Gap junctions.

Authors:  Morten Schak Nielsen; Lene Nygaard Axelsen; Paul L Sorgen; Vandana Verma; Mario Delmar; Niels-Henrik Holstein-Rathlou
Journal:  Compr Physiol       Date:  2012-07       Impact factor: 9.090

Review 6.  Connexin43 phosphorylation in brain, cardiac, endothelial and epithelial tissues.

Authors:  Lucrecia Márquez-Rosado; Joell L Solan; Clarence A Dunn; Rachael P Norris; Paul D Lampe
Journal:  Biochim Biophys Acta       Date:  2011-07-26

Review 7.  Translational lessons from scarless healing of cutaneous wounds and regenerative repair of the myocardium.

Authors:  Joseph A Palatinus; J Matthew Rhett; Robert G Gourdie
Journal:  J Mol Cell Cardiol       Date:  2009-06-25       Impact factor: 5.000

Review 8.  Increasing gap junctional coupling: a tool for dissecting the role of gap junctions.

Authors:  Lene Nygaard Axelsen; Ketil Haugan; Martin Stahlhut; Anne-Louise Kjølbye; James K Hennan; Niels-Henrik Holstein-Rathlou; Jørgen Søberg Petersen; Morten Schak Nielsen
Journal:  J Membr Biol       Date:  2007-06-14       Impact factor: 1.843

Review 9.  Gene therapies for arrhythmias in heart failure.

Authors:  Fadi G Akar; Roger J Hajjar
Journal:  Pflugers Arch       Date:  2014-02-26       Impact factor: 3.657

10.  NCAM(CD56) and RUNX1(AML1) are up-regulated in human ischemic cardiomyopathy and a rat model of chronic cardiac ischemia.

Authors:  Stefan Gattenlöhner; Christiane Waller; Georg Ertl; Burkhard-Dieter Bültmann; Hans-Konrad Müller-Hermelink; Alexander Marx
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.